Updated Overall Survival and Time to Progression Results in NETs Treated with Everolimus Combination with Octreotide LAR As First-Line Treatment.

Journal of clinical oncology(2014)

引用 0|浏览35
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要